By InvitationNot Applicable

The Effect of Virtual Reality in Older Adults

Turkey (Türkiye)60 participantsStarted 2026-03-01

Plain-language summary

This research will be conducted to examine the effects of virtual reality on sleep quality and comfort in older adults. This research will be conducted as a single-blind, randomized controlled experimental study with a pre-test-post-test design, involving application and control groups, to examine the effect of virtual reality on sleep quality and comfort in elderly adult patients hospitalized in the internal medicine and surgical clinics of Kars Harakani State Hospital between December 15, 2025, and December 31, 2026. To inform older adults, and after obtaining informed consent, the study will be administered using a "Senior Adult Descriptive Information Form" containing demographic information about older adults, the Standardized Mini Mental Test which assesses the cognitive level of older adults, and a "Senior Adult Monitoring Form" to track any potential side effects of the intervention. The Senior Adult Descriptive Information Form, the Richards-Campbell Sleep Scale (RCSQ), and the VAS Comfort Scale (VCS) will be used to collect data for the study. Data will be collected from elderly adults hospitalized in the internal medicine and surgical clinics of Kars Harakani State Hospital who meet the research criteria. They will be shown 360-degree video images (Chitra and Eremita 2023; Eremita and Chitra 2024) for 20 minutes each night during their hospitalization hours using VR Shinecon virtual reality glasses.

Who can participate

Age range60 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Older adults willing to participate in the study * Being 60 years of age or older * Not having been diagnosed with Parkinson's disease or a psychiatric disorder, not having cognitive impairment, and being able to communicate * Absence of a sleep apnea diagnosis * Scoring 24 or higher on the Standardized Mini Mental Test * The participant stated that her average nightly sleep duration is less than 5 hours * Avoid using medications that may affect sleep (acetylcholinesterase inhibitors, beta-blockers, diuretics, phenytoin, theophylline, benzodiazepines, etc.) * Hospital stay must be at least 3 days * Avoid smoking in the last 15 minutes before a session and avoid using caffeine stimulants (tea/coffee/chocolate/cola etc.) exceeding 1.4 mg/kg in the 10 hours prior. * Lack of photosensitivity * Eye disease and absence of contact lenses Exclusion Criteria: * Those unwilling to participate in the study * Those who are not 60 years of age or older * Patients diagnosed with Parkinson's disease and psychiatric disorders, who have cognitive impairment and are unable to communicate * Having a diagnosis of sleep apnea * Those who score below 24 on the Standardized Mini Mental Test * Those who stated that their average nightly sleep duration is more than 5 hours * Those who use medication (acetylcholinesterase inhibitor, beta blocker, diuretic, phenytoin, theophylline, benzodiazepine etc.) that can affect sleep * Hospital stay of 3 days or less * Smoking a cigarett…

What they're measuring

Sleep quality

Timeframe: 1st midterm test: second day, 2nd midterm test: third day, final test: fourth day

Trial details

NCT IDNCT07499245

SponsorKafkas University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-12